HOME >> BIOLOGY >> NEWS
Oral contraceptives increase C-reactive protein, an infIammatory biomarker

April 9, 2003 (San Diego, CA) When women think about birth control, estrogen, and cardiovascular risk, they often assume that there are no answers. They would appear to be correct.

On the one hand, new pharmacological advancements have provided combination oral contraceptive (OC) formulations with lower-dose estrogen. These formulations have significantly less risk of cardiovascular adverse events compared to the older combined formulations with higher doses. They also provide excellent cycle control, a low incidence of breakthrough bleeding and spotting, and increased patient satisfaction.

On the other hand, the current generation progestins appear less safe than earlier formulations with respect to the risk of blood clotting. Moreover, recent studies have associated current oral contraceptive use with risks for ischemic stroke and myocardial infarction, impaired blood anticoagulant pathways, and increased cardiovascular reactivity. Thus, cardiovascular risk relating to consumption of oral contraceptives still remains.

C-reactive protein (CRP) is a protein in the body whose level increases when blood vessels become inflamed. Measuring cardiovascular risk is thought to be possible by assessing CRP levels. Previously published data has shown that blood levels of CRP are elevated many years before a first heart attack or stroke occurs. Accordingly, a team of researchers set out to investigate the association between current low-dose oral contraceptives and levels of plasma CRP.

A New Study

The authors of "Oral Contraceptive Use and Increased Plasma Concentration of C-reactive Protein" are Darlene M Dreon, DrPH; Joanne L Slavin, PhD; and Stephen D Phinney, MD, PhD, from Galileo Pharmaceuticals, Inc, Santa Clara, CA and the University of Minnesota, St. Paul, MN. They will present their findings at the American Physiological Society's upcoming conference, Experimental Biology 2003, being held April 11-15, 2003,
'"/>

Contact: Donna J. Krupa
djkrupa1@aol.com
American Physiological Society
9-Apr-2003


Page: 1 2 3

Related biology news :

1. Synthetic hormone used in contraceptives and HRT produces negative effects in monkey studies
2. Study suggests newer oral contraceptives may be less harmful for women smokers
3. USC study links historical increases in life span to lower childhood exposure to infection
4. Study narrows search for genes placing men at increased risk for prostate cancer
5. Rare mutations can significantly increase risk factor for heart disease
6. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
7. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
8. Study links high carbohydrate diet to increased breast cancer risk
9. Carnivore species are predicted to be at increased extinction risk from human population growth
10. DFG announces three percent budget increase
11. Animal research suggests plant estrogens in soy do not increase breast cancer risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2018)... (PRWEB) , ... July 31, 2018 , ... GSL ... connect seamlessly with LabArchives , the leading cloud-based Electronic Lab Notebook (ELN) platform. ... LabArchives enables researchers to store all of their research data records in a secure, ...
(Date:7/28/2018)... ... 2018 , ... Inthirani Arul, an evidence-based healer, today announces research results based ... autoimmune disorders. , Biomarkers for immune function, blood, as well as, inflammation, were ... 110% increase in overall immunity as seen by the rise in antibody levels , ...
(Date:7/26/2018)... ... , ... The Conference Forum has confirmed the agenda for the 5th Annual ... the Marriott Copley Place in Boston, MA. , Daniel Karlin, MD, Head of Experimental ... to lead the discussion on how and when to implement mobile/digital technology in clinical ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... (PRWEB) , ... July 25, 2018 , ... ... a biofield energy treated proprietary nutraceutical to combat inflammation and autoimmune disorders. ... as, immune function response. The following data was reported:, ...
(Date:7/24/2018)... ... 2018 , ... Mark Stutheit, an evidence-based energy healer, today ... improve anti-inflammatory, and immune function responses. , Biomarkers for systemic and organ-specific inflammation, ... reduced. Results are as follows:, , More than 40% ...
(Date:7/22/2018)... ... July 19, 2018 , ... Mitotech S.A, ... Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Under the ... with approximately $17m allocated towards the first Phase 3 study starting as early ...
(Date:10/12/2017)... ... October 12, 2017 , ... They call it ... biological network, a depiction of a system of linkages and connections so complex ... associate professor of computer science at Worcester Polytechnic Institute (WPI) and director of ...
Breaking Biology Technology:
Cached News: